Company / Operating Income
Citius Pharmaceuticals, Inc. Operating Income History
FY2011-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$1.2M
FY2013
5-year range
-$1.2M / -$19.6K
FY2011-FY2013
Trend
-5927.8%
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -5928% YoY in FY2013, a notable deviation from the 2-year average annual change of -2952%.
Based on SEC 10-K filings.
-$1M in FY2013.
Declined from -$25,637 to -$1M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2013, operating income decreased 5927.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2013 | -$1.2M | -5927.8% |
| FY2012 | -$19.6K | +23.5% |
| FY2011 | -$25.6K | - |
As of FY2013 · SEC 10-K · Updated Jun 22, 2026